Standard BioTools: Q3 Earnings Snapshot
Standard BioTools: Q3 Earnings Snapshot
Standard BioTools: Q2 Earnings Snapshot
Standard BioTools: Q2 Earnings Snapshot
Moore Kuehn Encourages APRN, FRGI, LAB, and CPRI Investors to Contact Law Firm
/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...
LAB INVESTOR ALERT: Julie & Holleman LLP Announces Investigation of Proposed Merger Between Standard BioTools and SomaLogic
/PRNewswire/ -- Shareholder rights law firm Julie & Holleman LLP is investigating potential breaches of fiduciary duty relating to the proposed merger between...
Standard BioTools Announces Second Quarter 2022 Financial Results and Provides Strategic Update
Second quarter revenue of $18.8 million Completed $250 million strategic cash infusion from Casdin Capital and Viking Global Upgraded management team...
Standard BioTools Announces Conference Call and Webcast of Second Quarter 2022 Financial Results
SOUTH SAN FRANCISCO, Calif., July 25, 2022 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – unleashing tools to...